Allied Market Research

2025

Next Generation Infusion Pump Market

Next Generation Infusion Pump Market, by End User (Hospitals, Homecare Settings, Ambulatory Care Centers), by Product Type (Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient Controlled Analgesia Infusion Pumps, Insulin Infusion Pumps), by Application (Oncology, Gastroenterology, Inflammatory Bowel Disease, Pulmonary Diseases, Diabetes) and, by Availability (Onsite, Cloud): Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The report provides in-depth analysis of the market, outlining current trends, driving factors, restraints, and key areas of investment. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of the key players to increase their market share and sustain intense competition in the industry.

Segmental Analysis

The Next generation infusion pump market is segmented into by end user, by product type, by application, by availability as well as comprises the market estimations depending on regional and country level analysis.

Competitive Analysis

The company profile section of the report covers strategic developments, business overview, product offerings, and financial performance of the companies. It also highlights the strategies adopted by companies such as products launch, agreements, partnerships, acquisitions mergers, collaborations, joint ventures, research & development investment, and regional expansion in the past few years.

Key companies identified in the report include Smiths Medical, Inc., Halyard Health, Inc., Baxter International, Inc., B. Braun Melsungen AG, Ruspimed S.P.A, Merit Medical Systems, Inc., Hospira, Inc., Terumo Corporation, BD (Becton, Dickinson and Company), NIPRO Medical Corporation

Additional Customization Offered

  • Criss Cross/3rd level segmentation

  • Additional company profiles

  • Inclusion of new segmentations

  • Market strategies adopted by key players to sustain competition in the market

The Report Caters Below Key Points

  • The potential business segment

  • The highest revenue contributors

  • The estimated market demand at regional and country level

  • Top players and their detailed analysis

  • Industry and value chain analysis

Key Reasons to Buy the Report

  • Detailed country level segment analysis

  • Key supplier profiling and market share analysis

  • Major regions/country level quantitative and qualitative analysis

  • Free 20% customization and post-sales support

Next Generation Infusion Pump Market, by End User Report Highlights

Aspects Details
icon_5
By End User
  • Hospitals
  • Homecare Settings
  • Ambulatory Care Centers
icon_6
By Product Type
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Patient Controlled Analgesia Infusion Pumps
  • Insulin Infusion Pumps
icon_7
By Application
  • Oncology
  • Gastroenterology
  • Inflammatory Bowel Disease
  • Pulmonary Diseases
  • Diabetes
icon_8
By Availability
  • Onsite
  • Cloud
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Dickinson and Company), Halyard Health, Terumo Corporation, Hospira, Merit Medical Systems, B. Braun Melsungen AG, NIPRO Medical Corporation, Smiths Medical, Baxter International, BD (Becton, Ruspimed S.P.A

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Next Generation Infusion Pump Market, by End User

Opportunity Analysis and Industry Forecast, 2023-2032